Protara Therapeutics (NASDAQ:TARA) reported a narrower-than-expected GAAP net loss per share of $0.35 for Q2 2025, with revenue remaining at $0.0 million as the company is not yet commercial. The increased operational losses were attributed to higher R&D and administrative expenses, while the company continues to develop its lead asset, TARA-002, for bladder cancer and pediatric lymphatic malformations.
Want More Context? 🔎
Shares of Tesla (NASDAQ: TSLA) rose nearly 4% after CEO Elon Musk updated the status of the company's robotaxi fleet, amid indications that electric vehicle sales may be improving. Notably, wait times for the Model Y have increased from one to three weeks to four to six weeks, suggesting a rise in orders despite recent declines in sales over the first two quarters of the year. Want More Context? 🔎
Read moreOn Aug. 6, 2025, Richard Bernstein Advisors LLC reported to the U.S. Securities and Exchange Commission that it sold 26,314 shares of Apple (NASDAQ:AAPL) for $5.32 million during the second quarter of 2025. This transaction accounted for 0.13% of the firm's 13F reportable assets under management. Want More Context? 🔎
Read moreInvesting in the stock market through the S&P 500 index is a prudent choice for minimizing risk while gaining exposure to top U.S. companies. By mirroring this index over the long term, investors can potentially grow a $30,000 investment to over $1 million by retirement, despite occasional market downturns. Want More Context? 🔎
Read moreSuper Micro Computer (NASDAQ: SMCI) experienced a significant 21.3% decline in its stock price last week, contrasting with gains in the S&P 500 and Nasdaq Composite, following its fourth-quarter fiscal report that missed market expectations despite positive forward guidance. The drop comes amid strong performance from AI stocks, highlighting the impact of Supermicro's disappointing sales and earnings results. Want More Context? 🔎
Read moreThe Vanguard Dividend Appreciation ETF (NYSEMKT: VIG) is designed to track the S&P U.S. Dividend Growers Index, focusing on companies that have consistently increased dividends for at least 10 years. It excludes the highest-yielding 25% of stocks, offering a growth-oriented approach to dividend investing rather than a purely income-focused strategy. Want More Context? 🔎
Read moreThe "Magnificent Seven," a term from CNBC's Jim Cramer, includes leading tech companies: Apple, Microsoft, Alphabet, Amazon, Tesla, Nvidia, and Meta. While all but Nvidia have reported results, five of these stocks are considered solid buys, with two others recommended for monitoring as they grow increasingly interesting to investors. Want More Context? 🔎
Read more
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.
